ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,888Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 379

$1.08M Total Retail Price of All Prescriptions

Rank: 41 out of 379

372 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

28% of this provider’s 372 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

39% of this provider’s 372 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 2,479 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$137 was the average price of a prescription from this provider, compared to $278 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
HYDROCODONE-ACETAMINOPHEN 841 182 S3 1 12
TIZANIDINE HCL 609 138 2 25
GABAPENTIN 383 119 3 2
MORPHINE SULFATE ER 381 33 S2 4 36
OXYCODONE HCL 332 52 S2 5 15
LEVETIRACETAM 320 146 6 3
TOPIRAMATE 231 46 7 5
ZOLPIDEM TARTRATE 225 74 8 27
CARBAMAZEPINE 202 51 9 16
MELOXICAM 169 56 10 47
CLOPIDOGREL 145 111 11 54
CITALOPRAM HBR 142 51 12 28
CARBIDOPA-LEVODOPA 119 57 13 1
DIVALPROEX SODIUM ER 114 23 14 21
CYPROHEPTADINE HCL 111 32 R 15 138
PRIMIDONE 107 48 16 8
LAMOTRIGINE 107 19 16 7
FENTANYL 104 22 S2 18 35
LYRICA 100 36 19 14
BUSPIRONE HCL 96 54 20 65
PLAVIX 94 72 21 66
ENALAPRIL MALEATE 93 23 22 151
TRAZODONE HCL 93 34 22 36
AMANTADINE 91 54 24 19
BACLOFEN 90 20 25 10
OXYCODONE HCL-ACETAMINOPHEN 82 34 S2 26 48
VIMPAT 80 25 27 26
CARISOPRODOL 74 0 R 28 40
ETODOLAC 73 15 29 166
VERAPAMIL ER 73 15 29 117
ROPINIROLE HCL 71 27 31 9
METHOCARBAMOL 65 18 R 32 88
HYDROCODONE BIT-IBUPROFEN 62 19 S3 33 82
CLONIDINE HCL 58 29 34 179
LACTULOSE 53 16 35 185
COPAXONE 53 20 35 13
CARBAMAZEPINE ER 52 14 37 97
ONDANSETRON HCL 51 11 38 188
PRAMIPEXOLE DIHYDROCHLORIDE 50 34 39 11
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.